• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与抗同种异体I类H-2免疫反应的CD4+ T细胞的异质性。主要增殖细胞与辅助细胞毒性T细胞反应的辅助细胞之间的功能区分。

Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.

作者信息

Kitagawa S, Sato S, Azuma T, Shimizu J, Hamaoka T, Fujiwara H

机构信息

Biomedical Research Center, Osaka University Medical School, Japan.

出版信息

J Immunol. 1991 Apr 15;146(8):2513-21.

PMID:1673140
Abstract

MLR in various combinations with class I H-2 disparity revealed that there are three patterns of MLR in the aspect of responding T subset (CD4 vs CD8) dominance. Irrespective of the CD8 vs CD4 dominance, a single i.v. administration of class I-disparate allogeneic spleen cells resulted in almost complete abrogation of anti-class I proliferative capacity of both CD4+ and CD8+ T cells in six combinations. The suppression of proliferative responses was correlated with the striking reduction in the ability to produce IL-2 upon stimulation with the relevant class I alloantigens. In contrast, i.v. presensitized recipient mice exhibiting only marginal MLR/Il-2 production could generate comparable magnitudes of anti-allo class I CTL as well as graft rejection responses to those induced by normal unpresensitized mice. The administration in vivo of anti-CD4 antibody along with the i.v. presensitization not only suppressed the generation of CTL responses by spleen cells but also induced appreciable prolongation of allo-class I-disparate skin grafts under conditions in which neither alone did it. These results demonstrate that 1) the suppression of graft rejection responses is not necessarily reflected on the reduction of MLR; 2) CD8+ CTL precursors responsible for graft rejection can be activated by either allo-class I-reactive CD8+ or CD4+ Th cells; 3) i.v. presensitization induces functional elimination of CD8+ and CD4+ proliferative/IL-2-producing T cells but not of CD8+ CTL precursors and CD4+ Th whose capacity is expressed by assistance of CTL induction but not by their own proliferation. Thus, this study illustrates the heterogeneity of class I alloantigen-reactive CD4+ T cells in the aspect of their capacity to proliferate themselves vs contribute to CTL induction as well as graft rejection.

摘要

将I类H - 2差异与MLR以各种组合方式进行研究,结果显示在反应性T细胞亚群(CD4与CD8)优势方面存在三种MLR模式。无论CD8与CD4的优势情况如何,单次静脉注射I类不同的同种异体脾细胞,在六种组合中均导致CD4⁺和CD8⁺ T细胞的抗I类增殖能力几乎完全丧失。增殖反应的抑制与用相关I类同种异体抗原刺激时产生IL - 2能力的显著降低相关。相反,仅表现出轻微MLR/IL - 2产生的静脉预致敏受体小鼠,能够产生与正常未预致敏小鼠诱导的抗同种异体I类CTL以及移植排斥反应相当的反应。体内注射抗CD4抗体与静脉预致敏同时进行,不仅抑制了脾细胞产生CTL反应,还在单独一种处理均无法做到的条件下,使I类不同的同种异体皮肤移植明显延长。这些结果表明:1)移植排斥反应的抑制不一定反映在MLR的降低上;2)负责移植排斥的CD8⁺ CTL前体细胞可被I类同种反应性CD8⁺或CD4⁺ Th细胞激活;3)静脉预致敏诱导CD8⁺和CD4⁺增殖性/产生IL - 2的T细胞功能消除,但不影响CD8⁺ CTL前体细胞和CD4⁺ Th细胞,其能力通过CTL诱导的辅助作用而非自身增殖来表达。因此,本研究说明了I类同种异体抗原反应性CD4⁺ T细胞在自身增殖能力与对CTL诱导及移植排斥的贡献方面的异质性。

相似文献

1
Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.参与抗同种异体I类H-2免疫反应的CD4+ T细胞的异质性。主要增殖细胞与辅助细胞毒性T细胞反应的辅助细胞之间的功能区分。
J Immunol. 1991 Apr 15;146(8):2513-21.
2
Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.I类H-2同种异体抗原反应性Lyt-2+辅助性T细胞亚群的特性。通过静脉注射I类H-2不同的同种异体细胞消除其增殖和产生白细胞介素-2的能力。
J Immunol. 1988 Aug 1;141(3):721-7.
3
Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.同种异体II类H-2抗原反应性L3T4+辅助性T细胞的耐受性诱导及相应II类H-2不相合皮肤移植物的长期存活。
J Immunol. 1989 Sep 1;143(5):1447-52.
4
Tolerance induction of allo-class I H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class I H-2-disparate skin graft.同种I类H-2抗原反应性Lyt-2+辅助性T细胞的耐受性诱导及相应I类H-2不相合皮肤移植物的长期存活。
J Immunol. 1989 Jul 1;143(1):1-8.
5
Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.肿瘤同种异体移植排斥主要由受I类同种异体抗原刺激的CD8 + 细胞毒性T淋巴细胞介导,并与识别II类同种异体抗原的CD4 + 辅助性T细胞协同作用。
J Immunol. 1990 Mar 15;144(6):2425-35.
6
Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.移植排斥反应中的细胞间相互作用:针对共表达于耐受原上的同种异体II类H-2抗原的免疫反应可阻止抗同种异体I类H-2耐受性的诱导。
J Exp Med. 1992 Jan 1;175(1):99-109. doi: 10.1084/jem.175.1.99.
7
Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.通过使CD8 +辅助性T细胞失活诱导抗同种异体I类H-2耐受性,并通过引入第三方辅助性T细胞逆转耐受性。
J Exp Med. 1990 Jul 1;172(1):105-13. doi: 10.1084/jem.172.1.105.
8
Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.I类主要组织相容性复合体不相合组合中的异质性移植排斥途径及其对相关同种异体抗原静脉预致敏诱导的免疫调节的不同易感性。
J Exp Med. 1991 Sep 1;174(3):571-81. doi: 10.1084/jem.174.3.571.
9
Requirement of the thymus for the recovery of anti-alloantigen helper T cells from tolerance induced by intravenous presensitization with allogeneic cells.胸腺对于从经同种异体细胞静脉预致敏诱导的耐受中恢复抗同种异体抗原辅助性T细胞的必要性。
J Immunol. 1990 Jun 1;144(11):4139-46.
10
Two roles for CD4 cells in the control of the generation of cytotoxic T lymphocytes.CD4细胞在控制细胞毒性T淋巴细胞生成过程中的两种作用。
J Immunol. 1991 Jan 1;146(1):3-10.

引用本文的文献

1
The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.新型免疫抑制剂FTY720对无次级淋巴器官小鼠的作用。
Surg Today. 2005;35(8):662-7. doi: 10.1007/s00595-005-3011-x.
2
Partial tolerance of subcutaneously transplanted xenogeneic tumour cell graft by Fas-mediated immunosuppression.通过Fas介导的免疫抑制实现皮下移植异种肿瘤细胞移植物的部分耐受性
Immunology. 2001 May;103(1):81-9. doi: 10.1046/j.1365-2567.2001.01223.x.
3
Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
移植排斥反应中的细胞间相互作用:针对共表达于耐受原上的同种异体II类H-2抗原的免疫反应可阻止抗同种异体I类H-2耐受性的诱导。
J Exp Med. 1992 Jan 1;175(1):99-109. doi: 10.1084/jem.175.1.99.
4
Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.I类主要组织相容性复合体不相合组合中的异质性移植排斥途径及其对相关同种异体抗原静脉预致敏诱导的免疫调节的不同易感性。
J Exp Med. 1991 Sep 1;174(3):571-81. doi: 10.1084/jem.174.3.571.